Biologic Therapies for Psoriasis Do Not Up CV Risk - Doctors Lounge

Biologic Therapies for Psoriasis Do Not ahead CV Risk Doctors couch Biologic therapies anti-interleukin (IL)-12 and IL-23 and anti-tumor necrosis factor α in patients with chronic speckle psoriasis do not gain the risk of great adverse cardiovascular events, according to a meta-analysis published online Aug. ... disease of the skin , Biologics: Concern physical object About CV Risks house Practice News Digital system Certain biologic therapies for psoriasis do not seem to increase risk for ... EurekAlert (press release) Association Between Biologic Therapies for Chronic Plaque disease of the skin and ... Journal of American Medical Association (subscription) all 9 news articles » Link To Article